Collectively, the data reported here support the conclusion that FAK enhances in vitro HNSCC cell invasion activity, at least in part, by promoting both increased cell motility and MMP-2 secretion; thus, these data provide new insights into possible therapeutic intervention strategies for HNSCC. This evidence concerns the gene PTK2 and head and neck squamous cell carcinoma.